SCHEDULE: Fractyl Health: CVF, HCC Manager Disclose 3.4% Passive Stake
Beneficial Ownership Disclosure
CVF, LLC and HCC Manager LLC have filed an amended Schedule 13G, disclosing a combined beneficial ownership of 3.4% of Fractyl Health, Inc.'s common stock.
Summary
- CVF, LLC and HCC Manager LLC jointly reported beneficial ownership of 4,673,870 shares of Fractyl Health, Inc. common stock.
- This represents 3.4% of the total 137,044,440 shares outstanding as of October 31, 2025.
- The filing is an Amendment No. 1 to a Schedule 13G, indicating a change from a previous filing.
- Both reporting persons disclaim intent to change or influence control of Fractyl Health, Inc., consistent with a passive investment strategy.
- The filing date for this amendment is February 4, 2026.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral filing, as it is a standard regulatory disclosure of passive beneficial ownership and does not contain new information regarding the issuer's operational or financial performance.
Positives
- A significant institutional investor group maintains a stake in Fractyl Health, Inc., indicating continued confidence.
- The filing confirms a passive investment intent, reducing concerns about potential activist interventions.
Negatives
- The filing does not explicitly state if the 3.4% ownership represents an increase or decrease from previous holdings, making it difficult to assess investor sentiment change based solely on this document.
Risks
- No specific risks related to Fractyl Health, Inc.'s operations or financial health are disclosed in this ownership filing.
Future Outlook
The filing is an ownership disclosure and does not contain forward-looking statements or guidance regarding Fractyl Health, Inc.'s future performance or strategic direction.
Management Comments
- Richard Robb, Executive Vice President for both CVF, LLC and HCC Manager LLC, certified that the securities were not acquired or held for the purpose of changing or influencing control of the issuer, other than activities solely in connection with a nomination under Rule 14a-11.
Industry Context
StockSavvy.ai notes that Schedule 13G filings are routine disclosures for passive investors holding less than 5% of a company's outstanding shares. For a company like Fractyl Health, Inc., which operates in the healthcare/biotechnology sector, institutional ownership is common and can provide a level of stability, though this specific filing does not indicate any new strategic industry trends.
Comparison to Industry Standards
- This filing is a standard disclosure of beneficial ownership and does not contain performance metrics that would allow for a direct comparison to industry benchmarks or specific comparable companies.
- The 3.4% stake is below the 5% threshold that often triggers more active investor scrutiny or engagement, aligning with a passive investment strategy common among institutional holders.
Management Changes
| Role | Previous Person | New Person | Effective Date | Reason |
|---|---|---|---|---|
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
Legal Proceedings
- No legal proceedings or regulatory matters concerning Fractyl Health, Inc. are disclosed in this filing.
Related Party Transactions
- No related party transactions involving Fractyl Health, Inc. are disclosed in this filing.
Stakeholder Impact
- Shareholders: Provides transparency regarding a significant passive institutional holder's stake.
- Management: Confirms a passive investment approach from CVF, LLC and HCC Manager LLC, reducing immediate pressure from this specific investor group.
Next Steps
- No specific future actions or milestones for Fractyl Health, Inc. are mentioned in this ownership filing.
Key Dates
| Date | Description |
|---|---|
| 2025-10-31 | Date as of which 137,044,440 shares of Common Stock were reported outstanding by Fractyl Health, Inc. in its Form 10-Q. |
| 2025-11-12 | Date Fractyl Health, Inc. filed its Quarterly Report on Form 10-Q with the SEC. |
| 2026-02-04 | Date of event requiring filing of this statement and signature date for the reporting persons. |
Recommendation
holdThis filing is a routine disclosure of passive beneficial ownership and does not provide new information about Fractyl Health, Inc.'s operational performance, financial health, or strategic direction that would warrant a change in investment recommendation. Investors should continue to hold based on their existing analysis of the company's fundamentals.
Keywords
Fractyl Health, CVF LLC, HCC Manager LLC, Schedule 13G, Beneficial Ownership, Common Stock, Passive Investment, SEC Filing, Healthcare, Biotechnology
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.